MAA Laboratories

MAA Laboratories is a specialty pharmaceutical company revolutionizing drug development through its patented NanoCont™ continuous manufacturing platform. This cutting-edge process enables the creation of differentiated, high-value medicines with strong intellectual property and lifecycle extension potential. MAA has achieved multiple regulatory milestones, including several IND approvals from the U.S. FDA and positive scientific advice from European regulators. The company is also advancing an aligned NDS filing strategy with Health Canada, showcasing its global regulatory expertise and ability to rapidly progress innovative drug development programs.